Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology (External (Non-Invasive) Neuromodulation, and Internal Neuromodulation); Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson
Publication Month: Oct 2020 | Report Code: TIPHE100001415 | No. of Pages: 195 | Category: Medical Device | Status: Published
The Neuromodulationmarket was valued at US$ 7,613.45 million in 2019 and is projected to reach US$ 16,333.98 million by 2027; it is expected to grow at a CAGR of 10.3%during 2020–2027.
Neurological disorders such as cerebrovascular diseases, Alzheimer’s disease, and Parkinson's disease can be treated with the help of neuromodulation that is performed by using various devices or infusing drugs. Devices used in neuromodulation Market involve the application of electrodes to the spinal cord, brain, or peripheral nerves.
Lucrative Regions in Neuromodulation Market
Get more information on this report :
Market Insights
Increasing Incidence of Neurological Disorders Drives Market Growth
Depression is the most common neurological disorder among all age groups. In the developing regions, most people suffer from depression owing to various socioeconomic factors such as financial stress and poverty. Other neurological disorders such as dystonia, Parkinson’s disease, and obsessive-compulsive disorder are usually observed in aging population. According to a study ‘Incidence and Prevalence of Major Neurologic Disorders,’ published in January 2018, ~36% of elderly have moderate or severe memory impairment in the US. Each year nearly 1.2 million adults are diagnosed with brain disorders, of which 51.3% is due to stroke and 21% due to Alzheimer’s disease. In addition, nearly 135 million people are diagnosed with Parkinson’s disease, traumatic brain injury, and epilepsy each year. Moreover, ~500,000 cases of brain tumor, multiple sclerosis, and amyotrophic lateral sclerosis are reported annually. Therefore, the growing prevalence of neurological disorders is consequently propelling the demand for neuromodulators as these help in relieving neurological symptoms. Furthermore, the rising demand for neurostimulation devices to treat chronic pain.
Products Insights
In terms of technology, the external (non-invasive) neuromodulation segment held a greater share of the neuromodulation market in 2019. The same segment is expected to continue its dominance and register a higher CAGR in the market during the forecast period.
Neuromodulation Market, by Technology – 2019 and 2027
Get more information on this report :
Application Insights
Based on application, the global neuromodulation market is segmented into chronic pain management, failed back syndrome, epilepsy, tremor, incontinence, depression, dystonia, gastroparesis, Parkinsons’s disease, obsessive-compulsive disorder, and migraine. The chronic pain management segment held the largest share of the market in 2019, and it is expected to register the highest CAGR during the forecast period.
Chronic pain management helps relieve pain with the use of drugs, therapies, and lifestyle changes. Electrical stimulation devices play a major role in pain management as they are primarily developed for relieving several types of chronic and acute pain.Growing geriatric population, increasing chronic condition prevalence, and sedentary lifestyle are a few of the risk factors that may cause chronic pain. For instance, according to a study published by Arthritis Foundation in 2019, aging population is responsible for the growing prevalence of all types of diseases across the world. The same study stated that1 in 3 people in the US suffers from arthritis each year. Therefore, the rising prevalence of chronic pain is expected to drive the growth of the segment during the forecast period.
The incorporation of advanced technologies in electrical stimulation devices enables additional benefits for pain management. For instance, in January 2019, Abbott announced test results of BurstDR stimulation developed for the treatment of chronic pain. The results show thatthe product reduces pain by around 60–70%.
Strategic Insights
By Technology
- External (Non-Invasive) Neuromodulation
- Respiratory Electrical Stimulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Internal Neuromodulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Gastric Electrical Stimulation
- Spinal Cord Stimulation
- Vagus Nerve Stimulation
By Application
- Chronic Pain Management
- Failed Back Syndrome
- Epilepsy
- Tremor
- Incontinence
- Depression
- Dystonia
- Gastroparesis
- Parkinson’s Disease
- Obsessive-Compulsive Disorder
- Migraine
By End User
- Hospitals
- Clinics
- Home Healthcare
By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Russia
Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
South and Central America
- Brazil
- Argentina
Company Profiles
- Abbott
- Boston Scientific Corporation
- Medtronic
- NeuroPace, Inc.
- NeuroSigma, Inc.
- NEVRO CORP.
- Synapse Biomedical Inc.
- Soterix Medical Inc
- Integer Holdings Corporation
- Magstim
Frequently Asked Questions
The List of Companies - Neuromodulation Market
- Abbott
- Boston Scientific Corporation
- Medtronic
- NeuroPace, Inc.
- NeuroSigma, Inc.
- NEVRO CORP.
- Synapse Biomedical Inc.
- Soterix Medical Inc
- Integer Holdings Corporation
- Magstim
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the neuromodulation market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global neuromodulation market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
-
$3000
-
$4550 $3640
-
$6550 $5240
-
$8550 $6840
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount